Zobrazeno 1 - 10
of 2 487
pro vyhledávání: '"Sacks, L"'
Autor:
Olson, M., Helfenbein, E., Su, L., Berg, M., Knight, L., Troy, L., Sacks, L., Sakai, D., Su, F.
Publikováno v:
In Resuscitation June 2018 127:95-99
Autor:
Michalareas, T., Sacks, L.
In this paper we present a combinatorial optimisation view on the routing problem for connectionless packet networks by using the metaphor of a landscape. We examine the main properties of the routing landscapes as we define them and how they can hel
Externí odkaz:
http://arxiv.org/abs/cs/0109028
Autor:
Robinson R; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Medical Policy, Silver Spring, MD, USA. Ryan.Robinson1@fda.hhs.gov., Sacks L; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Medical Policy, Silver Spring, MD, USA.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Feb 02. Date of Electronic Publication: 2024 Feb 02.
Autor:
Igo M; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA., Xu L; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA., Krishna A; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA., Stewart S; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA., Xu L; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA., Li Z; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA., Weaver JL; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA., Stone H; Office of Medical Policy, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA., Sacks L; Office of Medical Policy, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA., Bensman T; Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA., Florian J; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA., Rouse R; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA., Han X; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Gut microbes [Gut Microbes] 2023 Dec; Vol. 15 (2), pp. 2271150. Date of Electronic Publication: 2023 Oct 31.
Autor:
Motonaga KS; Department of Pediatrics, Division of Pediatric Cardiology, Stanford University, Palo Alto, CA, USA., Sacks L; Department of Pediatrics, Division of Pediatric Cardiology, Stanford University, Palo Alto, CA, USA., Olson I; Department of Pediatrics, Division of Pediatric Cardiology, Stanford University, Palo Alto, CA, USA., Balasubramanian S; Department of Pediatrics, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, MI, USA., Chen S; Department of Pediatrics, Division of Pediatric Cardiology, Stanford University, Palo Alto, CA, USA., Peng L; Department of Pediatrics, Division of Pediatric Cardiology, Stanford University, Palo Alto, CA, USA., Feinstein JA; Department of Pediatrics, Division of Pediatric Cardiology, Stanford University, Palo Alto, CA, USA., Silverman NH; Department of Pediatrics, Division of Pediatric Cardiology, Stanford University, Palo Alto, CA, USA., Hanley FL; Department of Cardiothoracic Surgery, Division of Pediatric Cardiac Surgery, Stanford University, Palo Alto, CA, USA., Axelrod DM; Department of Pediatrics, Division of Pediatric Cardiology, Stanford University, Palo Alto, CA, USA., Krawczeski CD; Department of Pediatrics, Division of Pediatric Cardiology, Nationwide Children's Hospital, Columbus, OH, USA., Arunamata A; Department of Pediatrics, Division of Pediatric Cardiology, Stanford University, Palo Alto, CA, USA., Kwiatkowski DM; Department of Pediatrics, Division of Pediatric Cardiology, Stanford University, Palo Alto, CA, USA., Ceresnak SR; Department of Pediatrics, Division of Pediatric Cardiology, Stanford University, Palo Alto, CA, USA.
Publikováno v:
Cardiology in the young [Cardiol Young] 2023 Oct; Vol. 33 (10), pp. 1975-1980. Date of Electronic Publication: 2022 Nov 28.
Autor:
Bishop, J.L., Tirsch, Daniela, Viviano, C., Lane, M.D., Tornabene, Livio L., Voigt, J.R.C., Grant, F.H., Loizeau, Damien, Sacks, L., Seelos, Frank
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1640::fc98a8c2a8a23db4c66220ae07dc2de5
https://elib.dlr.de/191058/
https://elib.dlr.de/191058/
Autor:
Sacks L; Office of Medical Policy, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA. Leonard.Sacks@fda.hhs.gov., Kunkoski E; Office of Medical Policy, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Noone M; Office of Pediatric Therapeutics, Office of Clinical Policy and Programs, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2022 Nov; Vol. 56 (6), pp. 929-933. Date of Electronic Publication: 2022 Mar 27.